Connect with us

Health

Low response rate reported for Amgen targeted drug in colon cancer trial



An experimental Amgen Inc drug that targets a specific genetic mutation shrank tumors in just one of 12 patients with advanced colorectal cancer who were given the highest dose in a small, early-stage trial, the company said on Saturday.





Source link

قالب وردپرس

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Providence
46°
Sunny
6:25am5:31pm EST
Feels like: 39°F
Wind: 19mph WNW
Humidity: 30%
Pressure: 30.06"Hg
UV index: 1
FriSatSun
43/30°F
50/36°F
45/39°F
Advertisement

Top News cnn